Live Price
Live Volume
Chart Volume 0
Volume 0
5 secGT Biopharma Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $5.07 |
|---|---|
| Close | $5.07 |
| Low | $5.07 |
| Low Change | 0.00 (0.00%) |
| High | $5.07 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 604 |
| Dollar Volume | $3.06K |
Regular Trading Hours Yesterday
-0.40(-7.29%)
| Open | $5.49 |
|---|---|
| Close | $5.09 |
| Low | $5.09 |
| Low Change | -0.40 (-7.29%) |
| High | $5.78 |
| High Change | +0.29 (+5.28%) |
| Range | $0.69 |
| Volume | 175.019K |
| Dollar Volume | $890.85K |
Premarket Yesterday
+0.00(+0.00%)
| Open | $5.38 |
|---|---|
| Close | $5.38 |
| Low | $5.38 |
| Low Change | 0.00 (0.00%) |
| High | $5.38 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 167 |
| Dollar Volume | $898.46 |
GT Biopharma News
There is no current news for this stock at the moment.
GT Biopharma Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
GT Biopharma Moving Averages
| 5 Day Moving Average (SMA5) | $5.75 |
|---|---|
| 10 Day Moving Average (SMA10) | $6.24 |
| 20 Day Moving Average (SMA20) | $6.32 |
| 50 Day Moving Average (SMA50) | $4.83 |
| 100 Day Moving Average (SMA100) | $2.61 |
| 200 Day Moving Average (SMA200) | $1.54 |
GT Biopharma Statistics
| Average Volume (30 Days) | 205.28K |
|---|---|
| P/E Ratio (Current) | -.37 |
| EPS (Current) | -$18.16 |
| Dividend Yield | 1.90% |
| Free Cash Flow | -$14.43M |
| Cash Ratio | 2.24 |
| Current Ratio | 2.61 |
| Quick Ratio | 2.61 |
| Debt to Equity | 0.00 |
| Enterprise Value | $7.09M |
| EV to EBITDA | -0.43 |
| EV to Sales | — |
| Price to Book | 3.38 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -5.66% |
| Return on Equity | -9.18% |
GT Biopharma Stock Splits
There have been 3 stock splits for GT Biopharma (GTBP). The last reverse stock split occured on September 8, 2026 and reduced the outstanding shares at a ratio of 25:1.
| Date | Type | Ratio |
|---|---|---|
| Sep 8, 2026 | Reverse | 25:1 |
| Feb 5, 2024 | Reverse | 30:1 |
| Feb 11, 2021 | Reverse | 17:1 |
GT Biopharma Dividends
There have been no dividends for GT Biopharma (GTBP).